Skip to main content
SpringerLink
Log in

Dünndarmtumoren

  • Chapter
Kompendium Internistische Onkologie

  • 106 Accesses

Zusammenfassung

Häufigkeit: Gut- und bösartige Neubildungen des Dünndarms sind vergleichsweise selten und machen lediglich 5–10% aller gastrointestinalen Tumoren aus. Zwei Drittel dieser Tumoren sind maligne, was einem Anteil von 0,1–0,3% aller bösartigen Erkrankungen entspricht. In den USA werden jährlich 2100–2400 Neuerkrankungen registriert, valide Inzidenzangaben für Deutschland liegen nicht vor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Baigrie RJ (1991) Seven different primary cancers in a single patient. A case report and review of multiple primary malignant neoplasia. Eur J Surg Oncol 17:81–83

    PubMed  CAS  Google Scholar 

  • Bakaeen FG, Murr MM, Sarr MH et al (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135(6):635–641

    Article  PubMed  CAS  Google Scholar 

  • Barnhill M, Hess E, Guccion JG et al (1994) Tripartite differentiation in a carcinoma of the duodenum. Cancer 73:266–272

    Article  PubMed  CAS  Google Scholar 

  • Barquist E, Zinner M (1993) Neoplasms of the small intestine, vermiform appendix and peritoneum. In: Holland JF, Frei E, Bast RC et al (eds) Cancer medicine. Lea & Febiger, Philadelphia London, pp 1485–1493

    Google Scholar 

  • Bastug DF, Cochran RC, Caldwell R, Foster D (1991) Adenocarcinoma of the small intestine in Crohn’s disease: a unique finding. W V Med J 87:295–298

    PubMed  CAS  Google Scholar 

  • Coit GC (1993) Cancer of the small intestine. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles & practice of oncology. JB Lippincott, Philadelphia, pp 915–928

    Google Scholar 

  • Del Vecchio R, La Torte P, Cotugno M, Costarelli L (1989) Adenocarcinoma of the duodenum associated with skin neurofibromatosis and Caroli’s disease. Minerva Chir 44:2421–2426

    PubMed  Google Scholar 

  • Dozois RR, Judd ES, Dahlin DC (1969) The Peutz-Jeghers syndrome: Is there a predisposition to the development of intestinal malignancy? Arch Surg 98:509517

    Google Scholar 

  • Fielding JR, Prior P, Waterhouse JA, Cooke WT (1972) Malignancy in Crohn’s disease. Scand J Gastroenterol 7:3–7

    Article  PubMed  CAS  Google Scholar 

  • Good CA (1963) Tumors of the small intestine. Am J Roentgenol 89:685–705

    CAS  Google Scholar 

  • Hart R, Levin B (1993) Neoplasnis of the small bowel. In: Calabresi P, Schein PS (eds) Medical oncology. Basic principles and clinical management of cancer. Mc Graw-Hill, New York, pp 741–747

    Google Scholar 

  • Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base 1985–1995. Cancer 86(12):2693–2706

    Article  PubMed  CAS  Google Scholar 

  • Jigyasu D, Bedikian AY, Stroehlein JR (1984) Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 53:23–25

    Article  PubMed  CAS  Google Scholar 

  • Jones MA, Griffith LM, West AB (1989) Adenocarcinoid tumor of the periampullary region: a novel duodenal neoplasm presenting as biliary tract obstruction. Hum Pathol 20:198–200

    Article  PubMed  CAS  Google Scholar 

  • Kaklamanos IG, Bathe OF, Franceschi D et al (2000) Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 179(1):37–41

    Article  PubMed  CAS  Google Scholar 

  • Kaminsky N, Shahm D, Eliakim R (1993) Primary turnours of the duodenum. Postgrad Med J 69:136–138

    Article  Google Scholar 

  • Kusumoto H, Kumashirso R, Kido K, Inutsuka S (1991) Simultaneous adenocarcinoma of the stomach and fourth portion of the duodenum: case report and review of the literature. Radiat Med 9:223–228

    PubMed  CAS  Google Scholar 

  • Laurent F, Raynaud M, Biset JM et al (1991) Diagnosis and categorization of small bowel neoplasms: Role of computed tomography. Gastrointest Radiol 16:115–119

    Article  PubMed  CAS  Google Scholar 

  • Lowell JA, Rossi RL, Munson JL, Braasch JW (1992) Primary adenocarcinoma of third and fourth portions of duodenum. Favourable prognosis after resection. Arch Surg 127:557–560

    PubMed  CAS  Google Scholar 

  • Lowenfels AB, Sonni A (1977) Distribution of small bowel tumors. Cancer Lett 3:83–86

    Article  PubMed  CAS  Google Scholar 

  • Lynch HT, Smyrk TC, Lynch PM et al (1989) Adenocarcinoma of the small bowel in Lynch syndrome II. Cancer 64:2178–2183

    Article  PubMed  CAS  Google Scholar 

  • Michelassi F, Erroi F, Dawson PJ et al (1989) Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 210:544–554

    Article  PubMed  CAS  Google Scholar 

  • Nishiyama KI, Yao T, Yonemasu H et al (2002) Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine. Oncol Rep 9(2):293–300

    PubMed  Google Scholar 

  • Ohkusa T, Ohtomo K, Yamamoto N, Fujimoto H (1991) Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy. Dig Dis Sci 36:1653–1656

    Article  PubMed  CAS  Google Scholar 

  • Panday SC, Go IH, Mravunac M, Koning RW de (1993) Obstructive jejunal adenocarcinoma in the Muir-Torre syndrome. Neth J Med 43:116–120

    PubMed  CAS  Google Scholar 

  • Poon MA, O’Connell MJ, Wieand HS et al (1991) Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9(11):1967–1972

    PubMed  CAS  Google Scholar 

  • Reddy VB, Husain AN, Gattuso P et al (1990) Synchronous adenocarcinomas of jejunum and cecum following transverse colon carcinoma. A case study. Mt Sinai J Med (NY) 57:34–36

    CAS  Google Scholar 

  • Rösch T, Lorenz R, Zenker K et al (1992) Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc 38:460–467

    Article  PubMed  Google Scholar 

  • Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ (1993) A cohort study of cystic fibrosis and malignancy. Br J Cancer 68:1025–1028

    PubMed  CAS  Google Scholar 

  • Surveillance, Epidemiology, and End Results Data (1987) J Natl Cancer Inst 78:653

    Google Scholar 

  • Weidmann B, Teipel A, Niederle N (1994) The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Cancer 73:2001–2002

    Article  PubMed  CAS  Google Scholar 

  • Wheeler JMD, Warren BF, Mortensen NJ et al (2002) An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50(2):218–223

    Article  PubMed  CAS  Google Scholar 

  • Yeung RS, Weese JL, Hoffmann JP et al (1993) Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 72:2124–2133

    Article  PubMed  CAS  Google Scholar 

  • Zucchetti F, Bellantone R, Frontera D et al (1991) Adenocarcinoma of the small intestine. Int Surg 76:230–234

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Schöffski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. H. Köhne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Schwerpunkt Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle/Saale

    Hans-Joachim Schmoll (Direktor der Klinik und Poliklinik für Innere Medizin IV) (Direktor der Klinik und Poliklinik für Innere Medizin IV)

  2. Onkologie-Hämatologie-Gastroenterologie-Hepatologie-Infektiologie, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, 07740, Jena

    Klaus Höffken (Direktor der Klinik und Poliklinik für Innere Medizin II) (Direktor der Klinik und Poliklinik für Innere Medizin II)

  3. Schwerpunkt Onkologie und Hämatologie, Universitätsmedizin Berlin, Charité-Campus Mitte Schumannstraße 20/21, 10117, Berlin

    Kurt Possinger (Direktor der Medizinischen Klinik II) (Direktor der Medizinischen Klinik II)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schöffski, P., Köhne, C.H., Schmoll, H.J. (2006). Dünndarmtumoren. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31303-6_211

Download citation

  • DOI: https://doi.org/10.1007/3-540-31303-6_211

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20657-6

  • Online ISBN: 978-3-540-31303-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation